Prestige Wealth Management Group LLC Regeneron Pharmaceuticals, Inc. Transaction History

Prestige Wealth Management Group LLC

$447 Million
Q1 2025

A detailed history of Prestige Wealth Management Group LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Prestige Wealth Management Group LLC holds 90 shares of REGN stock, worth $50,483. This represents 0.01% of its overall portfolio holdings.

Number of Shares

Previous 101 10.89%

Holding current value

$50,483

Previous $71,000 19.72%

% of portfolio

0.01%

Previous 0.02%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$634.14 - $744.83 $6,975 - $8,193	-11 Reduced 10.89%	90 $57,000
Q4 2024 Feb 11, 2025	BUY	$701.85 - $1046.91 $13,335 - $19,891	19 Added 23.17%	101 $71,000
Q3 2024 Nov 14, 2024	SELL	$1024.09 - $1201.76 $20,481 - $24,035	-20 Reduced 19.61%	82 $86,000
Q2 2024 Aug 06, 2024	SELL	$883.2 - $1071.19 $43,276 - $52,488	-49 Reduced 32.45%	102 $107,000
Q1 2024 Apr 26, 2024	SELL	$902.69 - $993.35 $14,443 - $15,893	-16 Reduced 9.58%	151 $145,000
Q4 2023 Apr 26, 2024	SELL	$775.18 - $881.7 $3,875 - $4,408	-5 Reduced 2.91%	167 $146,000
Q4 2023 Feb 08, 2024	SELL	$775.18 - $881.7 $3,875 - $4,408	-5 Reduced 2.91%	167 $146,000
Q3 2023 Apr 26, 2024	BUY	$692.45 - $844.37 $2,077 - $2,533	3 Added 1.78%	172 $141,000
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $2,077 - $2,533	3 Added 1.78%	172 $141,000
Q2 2023 Apr 26, 2024	SELL	$700.03 - $830.35 $204,408 - $242,462	-292 Reduced 63.34%	169 $121,000
Q2 2023 Aug 11, 2023	SELL	$700.03 - $830.35 $204,408 - $242,462	-292 Reduced 63.34%	169 $121,000
Q1 2023 Apr 26, 2024	BUY	$680.49 - $826.97 $210,951 - $256,360	310 Added 205.3%	461 $378,000
Q1 2023 May 16, 2023	BUY	$680.49 - $826.97 $199,383 - $242,302	293 Added 174.4%	461 $378,000
Q4 2022 Feb 07, 2023	SELL	$705.89 - $766.39 $7,764 - $8,430	-11 Reduced 6.15%	168 $121,000
Q3 2022 Nov 01, 2022	SELL	$573.97 - $724.32 $1,147 - $1,448	-2 Reduced 1.1%	179 $124,000
Q2 2022 Aug 10, 2022	BUY	$548.35 - $738.84 $3,290 - $4,433	6 Added 3.43%	181 $107,000
Q1 2022 May 05, 2022	SELL	$595.12 - $698.43 $174,370 - $204,639	-293 Reduced 62.61%	175 $122,000
Q4 2021 Feb 15, 2022	BUY	$543.48 - $670.97 $64,130 - $79,174	118 Added 33.71%	468 $295,000
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $125,712 - $149,130	219 Added 167.18%	350 $212,000
Q2 2021 Aug 12, 2021	SELL	$472.8 - $558.54 $1,891 - $2,234	-4 Reduced 2.96%	131 $73,000
Q1 2021 May 13, 2021	BUY	$446.73 - $548.2 $18,762 - $23,024	42 Added 45.16%	135 $64,000
Q4 2020 Feb 17, 2021	SELL	$478.3 - $607.98 $42,090 - $53,502	-88 Reduced 48.62%	93 $45,000
Q3 2020 Oct 26, 2020	BUY	$544.75 - $658.21 $17,432 - $21,062	32 Added 21.48%	181 $101,000
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $48,838 - $63,748	99 Added 198.0%	149 $93,000
Q1 2019 Aug 16, 2019	SELL	$372.08 - $439.57 $12,650 - $14,945	-34 Reduced 40.48%	50 $21,000
Q4 2018 Apr 16, 2019	BUY	$335.82 - $403.04 $28,208 - $33,855	84 New	84 $31,000

Others Institutions Holding REGN

# of Institutions

1,458

Shares Held

84.9M

Call Options Held

1.39M

Put Options Held

1.45M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $60.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prestige Wealth Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prestige Wealth Management Group LLC with notifications on news.

Account

Prestige Wealth Management Group LLC Regeneron Pharmaceuticals, Inc. Transaction History